Good Clinical Practice (GCP) Certification
Tuesday, June 2, 2015
8:00AM – 11:30 AM
Wolstein Research Building Auditorium, Room 1413
8:00 – 10:00 AM- GCP and PI Responsibilities:
This session will include discussions of the relationships between laws, regulations, guidelines, and standard operating procedures. Key obligations of sponsors, monitors and investigators and their inter-relationships will be described. Investigators completing the program will receive a GCP certificate that can be provided to sponsors.
10:15 - 11:30 AM- Ethical Considerations, Informed Consent and Financial Disclosure:
This session will include a brief historical perspective of ethical considerations in conducting clinical research. The elements and process for obtaining informed consent from potential study participants will be discussed and well as financial disclosure.
Registration is online at: http://research.case.edu/Education/OnlineCalendar.cfm.
Endeavour Scholarships and Fellowships
Endeavour Scholarships and Fellowships are the Australian Government’s internationally competitive, merit-based scholarship program that last year awarded up to AUD$272,500 per scholar for study, research or professional development opportunities between Australia and the world.
Endeavour Postgraduate Scholarships for eligible non-Australians including Americans and Canadians to undertake a postgraduate qualification either by coursework or research in any field in Australia for up to two years for a Masters or up to 4 years for a PhD.
Endeavour Research Fellowships for American and Canadian postgraduate research students and postdoctoral researchers to undertake 4-6 months of research in Australia.
Endeavour Executive Fellowships offer professional development opportunities of (1 to 4 months) for high achievers in business, industry, education or government from eligible participating countries.
Deadline for Applications: June 30, 2015 (Australian Eastern Standard Time)
For more information visit the ORAU webpage.
NIH Posts Reminder of Its Policy on Application Compliance
The National Institutes of Health (NIH) recently released a notice to remind applicants, both investigators and grants office officials, that to be fair to all concerned the NIH needs to consistently apply standards for application compliance.
In part, the notice states that NIH may withdraw any application identified during the receipt, referral and review process that is not compliant with the instructions in the SF 424 (R&R) Application Guide, the Funding Opportunity Announcement, and relevant NIH Guide Notices.
Examples of reasons an application may be withdrawn for non-compliance include:
Read the full notice at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-095.html.
- inclusion of biosketchs that do not conform to the required format
- applications that do not conform to page limit requirements
- applications submitted as new but containing elements of a resubmission or renewal application
- applications submitted after 5 pm local time
Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:
- For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)
- Addressable with peptides and/or proteins
- Exploratory, discovery and/or preclinical in nature
The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.
Application Deadline: July 1st, 2015
For more information visit the Ferring Pharmaceuticals webpage.
Limited Submission Reminder: W.M. Keck Foundation Research Program
Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).
The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.
Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.
Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:
- Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
- Have the potential to develop breakthrough technologies, instrumentation or methodologies.
- Have few, if any, peer groups pursuing comparable or related work.
- Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
- Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
- Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
- Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be